Today's Top Stories
View all
The Added Complication of Chronic Opioid Use Before Lumbar Fusion
HSS and Fit:match Collaborate to Bring AI-Powered Body Scanning and Movement Education to TCS New York City Marathon Runners
Best New Pain Management Technologies for 2026
Ankle Fracture Patients Can Take an Earlier Step
More Stories
View allArthritis Foundation and Founding Sponsor Zimmer Biomet Announce New Community Celebrating Life After Joint Replacement and Inspiring Others to Act on Severe Joint Pain
The Comeback Club connects people who have had joint replacement with those considering it.
Stryker completes acquisition of ZuriMED to enhance its shoulder offering
Stryker has completed its acquisition of ZuriMED, adding the FiberLocker System to its Sports Medicine portfolio.
Kuros Reports 40% YOY Sales Growth
How long can Kuros keep this sales growth rate going?
Get The Legs Moving Post-op – and the Bowels Will Follow
How soon should spine tumor patients ambulate and ‘wake-up’ their bowels?
J&J and Smith+Nephew Had a $34 Billion Ortho Deal on the Table. Then They Couldn’t Agree on a CEO.
Dr. Kenneth Pettine, CEO of Direct Regeneration, Unveils Breakthrough Regenerative Technologies Set to Disrupt Orthopedics, Pain Management, and Skincare
Dr. Kenneth Pettine, CEO of Direct Regeneration, announced a landmark portfolio of technologies poised to revolutionize the treatment of osteoarthritis, chronic pain...
Dual-Mobility Hips: More Stability, a Fracture Trade-Off?
Do dual mobility hip constructs elevate fracture risk?
DAIR to Be Selective: Keeping the Implant Doesn’t Mean Keeping Every Part
A newly published 411 patient, 7 hospital study of the European Bone and Joint Infection Society’s DAIR guidelines found a significant problem.
Aclarion Announces New Real-World Publication: Nociscan® Validated by Strong Agreement with Discography in Diagnosing Painful Lumbar Discs
Aclarion, Inc., announced the publication of a new, independent, peer-reviewed study, “MR Spectroscopy in the Diagnosis of Lumbar Discogenic Pain.”
Integra LifeSciences Reports Third Quarter 2026 Financial Results
Integra LifeSciences today reported financial results for the third quarter ending September 30, 2026.
When the Tumor Is Gone, but the Rods Aren’t Out of the Woods
How heroic and costly is total en bloc spondylectomy (TES)?
Big-Toe Fusion: Is “Stay Off It” Still the Best Advice?
Which joint arthrodesis patients should ambulate early?
Integra Cash Flow Surges as Sales Make a Slow Recovery
Now that Stu’s back at Integra, how’s it going so far?
Oct 27, 2026Best New Pain Management Technologies for 2026
Oct 26, 2026Arthritis Foundation and Founding Sponsor Zimmer Biomet Announce New Community Celebrating Life After Joint Replacement and Inspiring Others to Act on Severe Joint Pain
Oct 26, 2026Stryker completes acquisition of ZuriMED to enhance its shoulder offering
Oct 26, 2026Industry Executives
